Triple-negative breast cancer patients should undergo genetic screening

Most patients with triple-negative breast cancer should undergo genetic testing for mutations in known breast cancer predisposition genes, including BRCA1 and BRCA2, a study has found. The findings come from the largest analysis to date of genetic mutations in this aggressive form of breast cancer.

Read the whole article on Science Daily

More from Science Daily